Our univariate analysis found that in CRC patients, lower differentiation, advanced TNM stage, and lymph node metastasis were associated with higher expression of CD163+ TAM and lower expression of CD86+ TAM. This evidence concerns the gene CD163 and metastatic malignant neoplasm in the lymph nodes.